Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;5(6):359-73.
doi: 10.1177/1756285612457215.

An update on the management of chronic inflammatory demyelinating polyneuropathy

Kenneth C Gorson  1
Affiliations

An update on the management of chronic inflammatory demyelinating polyneuropathy

Kenneth C Gorson. Ther Adv Neurol Disord. 2012 Nov.

Abstract

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune mediated disorder of the peripheral nervous system with clinical features that include weakness, sensory loss, imbalance, pain and impaired ambulation which may lead to substantial disability. This review highlights current treatment strategies for CIDP, how best to utilize proven therapies such as intravenous immunoglobulin, oral prednisone, pulse dexamethasone, and plasma exchange, and when and how to use alternative immunosuppressive agents when first-line therapies are ineffective or poorly tolerated.

Keywords: CIDP; IVIg; demyelinating neuropathy; immune neuropathy; inflammatory polyneuropathy; treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The author has received financial compensation for speaking engagements from Grifols Pharmaceuticals.

References

    1. Ahlmen J., Andersen G., Hallgren G., Peilot B. (1998) Positive effects of tacrolimus in a case of CIDP. Transplant Proc 30: 4194. - PubMed
    1. Alshekhlee A., Basiri K., Miles J., Ahmad S., Katirji B. (2010) Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor alpha antagonists. Muscle Nerve 41: 723–727 - PubMed
    1. Ashman E., Gronseth G. (2012) Level of evidence reviews. Three years of progress. Neurology 79: 13–14 - PubMed
    1. Axelson H., Oberg G., Askmark H. (2008) Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP. J Neurol Neurosurg Psychiatry 79: 612–614 - PubMed
    1. Barnett M., Pollard J., Davies L., McLeod J. (1998) Cyclosporine A in resistant chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 21: 454–460 - PubMed

LinkOut - more resources